Tibet Rhodiola Pharmaceutical Holding (600211.SS) Stock Price
Tibet Rhodiola Pharmaceutical Holding Price
Revenue has compounded at 6.7% per year over the past 19 years to 2.95 B CNY. Earnings per share have grown at 31.1% per year over the last 19 years. Tibet Rhodiola Pharmaceutical Holding's net margin stands at 31.8%, up from 9.8% several years earlier. Tibet Rhodiola Pharmaceutical Holding currently offers a dividend yield of about 5.19%. The payout ratio is around 64% of earnings. The dividend has grown at 38.2% per year over the past 12 years.
Tibet Rhodiola Pharmaceutical Holding stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Tibet Rhodiola Pharmaceutical Holding business model & stock analysis
Frequently asked questions about Tibet Rhodiola Pharmaceutical Holding
5 analysts currently rate the Tibet Rhodiola Pharmaceutical Holding stock: 4 recommend buying, 1 holding and 0 selling.
Tibet Rhodiola Pharmaceutical Holding Analyst Price Targets 2026
Converted at the current exchange rate, the Tibet Rhodiola Pharmaceutical Holding share trades at 4.78 EUR (36.02 CNY).
The Tibet Rhodiola Pharmaceutical Holding share (600211.SS) is listed on 1 stock exchanges, including: Shanghai (600211.SS).
The expected revenue of Tibet Rhodiola Pharmaceutical Holding is 4.83 B CNY. This figure is based on current financial data and reflects the company's business performance.
The profit cannot currently be calculated for Tibet Rhodiola Pharmaceutical Holding.
The P/E ratio cannot be calculated for Tibet Rhodiola Pharmaceutical Holding at the moment.
The price-to-sales ratio (P/S) of Tibet Rhodiola Pharmaceutical Holding is currently 2.40. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Tibet Rhodiola Pharmaceutical Holding stock.
The Eulerpool Quality Score for Tibet Rhodiola Pharmaceutical Holding is 6/10.
The ISIN of Tibet Rhodiola Pharmaceutical Holding is CNE000000ZW7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Tibet Rhodiola Pharmaceutical Holding is 600211.SS. The ticker symbol is used to trade Tibet Rhodiola Pharmaceutical Holding shares on the stock exchange.
Tibet Rhodiola Pharmaceutical Holding stock
Tibet Rhodiola Pharmaceutical Holding Peer Group
Tibet Rhodiola Pharmaceutical Holding Ticker
Tibet Rhodiola Pharmaceutical Holding FIGI
All fundamentals and in-depth analysis of Tibet Rhodiola Pharmaceutical Holding
Our stock analysis for Tibet Rhodiola Pharmaceutical Holding stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tibet Rhodiola Pharmaceutical Holding. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.